<DOC>
	<DOCNO>NCT00823849</DOCNO>
	<brief_summary>1 . To evaluate efficacy Cilostazol Probucol alone combination atherosclerosis relate biomarker 2 . To evaluate safety Cilostazol Probucol alone combination atherosclerosis relate biomarker</brief_summary>
	<brief_title>Study Cilostazol Probucol Assess Their Effects Atherosclerosis Related Biomarker</brief_title>
	<detailed_description>Efficacy evaluation : Primary efficacy index : After 12 week treatment , change arteriosclerosis relate biomarker 4 modality group , compare base line information Secondary efficacy index : After 8 week treatment , change arteriosclerosis relate biomarker 4 modality group , compare base line information Safety evaluation : 1 . Adverse Event 2 . Vital Sign Physical Examination 3 . 12-lead ECG 4 . Laboratory Tests ( include blood routine examination , routine urine analysis , blood biochemistry examination , glycosylated hemoglobin )</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis Obliterans</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Probucol</mesh_term>
	<criteria>40~75yearold male female Clarified diagnosis type 2 diabetes mellitus Arteriosclerosis obliterans ( ASO ) diagnose ( ASO diagnose meet least one condition : ABI &lt; 1.0 ; The pulse popliteal artery dorsalis pedis artery weeken significantly different leave right side Intermittent claudication , diagnose ASO doctor Ultrasonogram show atherosclerotic plaque lower limb within 1 year Informed Consent Form Signature Has allergic history study drug Use one follow drug : antiplatelet anticoagulation agent except Aspirin , hypolipidemic agent except Statins Type 1 diabetes mellitus , specific diabetes mellitus , gestational diabetes mellitus Has severe ASO Fontaine IIb , Hemorrhagic tendency hemorrhagic disease ( gastrointestinal tract hemorrhage , etc . ) Had myocardial infarction , angina pectoris , cerebral infarction within last 3 month Congestive heart failure Is pregnant , potentially pregnant , breastfeed Severe hepatic insufficient severe renal insufficiency ( AST ALT 2.5 time high upper limit normal value range , serum creatinine 1.2 time high upper limit normal value range ) Persistent hardly control hypertension ( malignant hypertension , BP &gt; 160/100 mmHg ) Severe ventricular arrhythmia ( multiple multifocal premature ventricular contraction ) Has medical history include cardiac syncope primary syncope Has condition may prolong QT interval ( congenital long QT syndrome , take drug prolong QT interval , hypokalemia hypomagnesemia , etc . ) Has severe complication ( diabetes mellitus ketoacidosis , nonketotic hyperosmolar diabetic coma , malignant tumor , severe anaemia , severe hematologic disease , etc . ) Other condition would exclude subject study doctor 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>type 2 diabetes mellitus , Arteriosclerosis obliterans</keyword>
</DOC>